Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TSG101 |
| Upstream (Parents) |
|---|
| (<<) ADORA2B → TSG101 |
| (<<) ALDOA → TSG101 |
| (<<) ATP10B → TSG101 |
| (<<) CEBPD → TSG101 |
| (<<) DDR1 → TSG101 |
| (<<) ELF4 → TSG101 |
| (<<) HRAS → TSG101 |
| (<<) PPP1CA → TSG101 |
| (<<) PRKAB1 → TSG101 |
| (<<) PRKCD → TSG101 |
| (<<) RAB22A → TSG101 |
| (<<) RNF11 → TSG101 |
| Downstream (Children) |
|---|
| TSG101 → BAALC (>>) |
| TSG101 → EFHD2 (>>) |
| TSG101 → GSK3B (>>) |
| TSG101 → ILK (>>) |
| TSG101 → INPP5D (>>) |
| TSG101 → MAP3K11 (>>) |
| TSG101 → MCL1 (>>) |
| TSG101 → OVOL1 (>>) |
| TSG101 → PPP2R5B (>>) |
| TSG101 → RRAS2 (>>) |
| TSG101 → SF3A2 (>>) |
| TSG101 → THRA (>>) |
| TSG101 → TPP1 (>>) |
